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Abstract
Purpose To analyze the clinical pattern of
ocular toxoplasmosis (OT) in a referral centre
in Serbia.
Patients and methods The medical records of
consecutive patients admitted for OT to the
single referral centre for uveitis in Serbia
between 2006 and 2010 were retrospectively
analyzed. OT was diagnosed on the basis of
typical fundus lesions and positive serology
for Toxoplasma.
Results In a total of 457 uveitis patients, OT
was the third leading cause, with 59 patients
(12.9%). Most OT cases (73%) were monocular.
An active primary retinal lesion was observed
in 36% and recurrent OT in 64% patients.
Localization of lesions was central/paracentral
(44%), juxtapapillar (27%), peripheral (19%), and
multifocal (10%). Other ocular manifestations of
inflammation included vitritis (44%), anterior
uveitis (19%), and retinal vasculitis (10%).
Complications included choroidal
neovascularization in two and exudative retinal
detachment with cataract, glaucoma, and
cystoid macular oedema in one patient each.
The detection of Toxoplasma-specific IgM
antibodies in a single patient indicates a low
rate of OT concomitant with acute infection.
After treatment, the mean best-corrected visual
acuity (BCVA) increased significantly. However,
14 (24%) patients ended up legally blind in the
affected eye, of which 2 (3%) with bilateral
blindness, all with a very poor BCVA
(0.047±0.055) at presentation. Visual
impairment and treatment outcome were both
associated with central localization of lesions
(Po0.0001 and P¼ 0.006, respectively).
Conclusion OT is a significant cause of
posterior uveitis in Serbia. Patients should be
aware of the recurring nature of OT and react
immediately if symptoms occur.
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Introduction
Toxoplasma gondii is a cosmopolitan protozoan
parasite that has been estimated to infect
one-third of the global population. Although
generally mild and self-limiting in immuno-
competent individuals, Toxoplasma infection
may cause life-threatening disease in the
fetus and in the immunosuppressed host.
Historically, ocular disease was the first clinical
entity to be associated with toxoplasmosis1 and
has long been a well-known consequence of
congenital infection.
Ocular toxoplasmosis (OT) most often
presents as focal retinochoroiditis, which is
considered to be triggered by the reactivation of
dormant parasites in the retina.2 Lesions can
occur anywhere in the fundus and may be
vision-threatening if localized in the posterior
pole. Toxoplasmosis is actually the most
common cause of infectious posterior uveitis
worldwide.2 Formerly considered to result
mainly from congenital infection,3 OT has in the
past decades been well established to occur both
after congenital and acquired infection.1,2,4–7
Indeed, a greater frequency of acquired than
congenital infection in the origin of OT has been
reported in several clinical series, both in
Europe and in South America.4–6 However, it
appears that congenital infections cause a more
severe OT.6 The geographic differences in
the epidemiology of OT reflect the genetic
variability in the parasite strains occurring in
the respective regions; that is, strains from
South America, responsible for the often severe
clinical course of toxoplasmosis on this
continent, are often type-1, or recombinant, and
generally divergent from those in Europe and
North America where a vast majority of all
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isolates belongs to type-2.8–11 In Serbia, the
seroprevalence of toxoplasmosis is currently estimated at
30–35%12 and type-2 genospecies has been isolated.13
As fetal infection may only develop following
maternal primary infection in pregnancy, congenital
toxoplasmosis is a preventable disease; therefore, the
incidence of OT of congenital origin may be expected to
decrease in line with successful prevention strategies
implemented in a particular milieu. However, acquired
infection, which is often inapparent and therefore
clinically unrecognized, and the recognition of its role in
the origin of OT, is responsible for the currently increased
interest in the study of OT.
Because the frequency and characteristics of OT have
never been reported for Serbia, we conducted a study to
analyze the clinical pattern of OT in a Serbian referral centre.
Patients and methods
A retrospective analysis of the medical records of
consecutive patients admitted for OT to the Uveitis
Department of the Institute for Eye Diseases in Belgrade
between 01 January 2006 and 31 December 2010 was
performed. This department is the single referral centre
for uveitis in Serbia. All patients underwent complete
ophthalmological examination, including clinical history,
visual acuity (VA) assessment (measured by Snellen
chart at 6 m and converted to decimal notation),
applanation tonometry, slit lamp examination, and
fundus examination with the three-mirror lens. In
addition, fundus photography, fluorescein angiography,
and optical coherence tomography were performed if
clinically appropriate.
OT was diagnosed on the basis of clinical findings in
the fundus and positive serology for Toxoplasma. Active
OT was defined as the presence of an active whitish focal
retinochoroidal lesion in either eye; if no associated
pigmented retinochoroidal scars were present in either
eye, it was considered primary OT and conversely, if
there was a scar in either eye, OT was considered
recurrent (termed satellite if localized at the borders of
the scars). In patients with two or more episodes, the last
episode of active OT was the one analyzed.
Detection of IgG and IgM antibodies specific for
T. gondii was performed using an ELISA test (Enzygnost
Toxoplasmosis IgG and Enzygnost Toxoplasmosis IgM
tests, Siemens Healthcare Diagnostics, Marburg,
Germany) according to the manufacturer’s instructions.
The test for IgG antibody was quantitative and the results
were expressed in IU/ml, whereas the one for IgM
antibody was qualitative.
The study has followed the tenets of the Declaration of
Helsinki and was approved by the Ethics Committee of
the Clinical Centre of Serbia.
Data were analyzed using SPSS 15.0 (SPSS Inc.,
Chicago, IL, USA). Methods used included Student’s
t-test for comparison of numerical variables and w2 or
Fischer’s exact test (as appropriate) for categorical
variables. The level of statistical significance was 0.05.
Results
A total of 457 patients were admitted for uveitis during
the study period, in whom OT was diagnosed in 59
(12.9%) patients. OT was the third leading cause of
uveitis after anterior serofibrinous uveitis (n¼ 131,
28.7%) and retinal vasculitis (n¼ 75, 16.4%). Of all the
uveitis patients, above one-half (53%) had posterior
uveitis (n¼ 243). Of these, OT accounted for 24.3% and
was the second most common cause after retinal
vasculitis. Importantly, OT was the most common cause
of infectious uveitis.
Toxoplasma-specific IgG antibodies were detected in
all patients, at a mean concentration of 96.4±15.8 IU/ml,
ranging from 10–350 IU/ml. Specific IgM antibody was
detected in a single patient, who was thus considered as
acute infection.
Baseline demographic and clinical characteristics of
patients with OT are shown in Table 1. The annual
number of OT cases was 12, 10, 10, 11, and 16,
respectively, for the period 2006–2010. Most (76%)
patients were admitted for OT only once; among the 14
who were admitted twice or more, the mean follow-up
(±SD) was 4.2±2.8 years (ranging from 1 to 9 years).
Female patients were slightly predominant (58%).
Patients were relatively young (mean 34.9±16.6 years),
with 76% younger than 45 years.
Of the 59 cases of OT, 43 (73%) were monocular and
16 (27%) binocular. In all the binocular cases, active OT
was present in one eye and old scars were observed in
the other. The eye with active OT was used to classify the
localization of retinochoroidal lesions. In the analysis
of the lesion localization, juxtapapillar lesions were
considered central if within the vascular arcades and
peripheral if outside, and similarly, multifocal lesions
were considered central if at least one lesion was within
the vascular arcades and peripheral if all foci were out of
the vascular arcades.
According to medical history data, the current OT
episode was the first one the patients were aware of in
42% and a recurrence in 58%. However, on clinical
examination, active primary retinal lesions were
observed in 36% and one or more satellite lesions in
64%. Although patients with primary OT were older
(38.0±20.2 years) than those with recurrent OT
(33.2±14.3), this difference was not significant
(P¼ 0.291).
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In addition to the OT-defining lesions, the clinical
presentation quite frequently included other
manifestations of ocular inflammation. In contrast,
complications were rare (Table 1).
Treatment was initiated immediately after diagnosis
and included systemic Clindamycin 20–30 mg/kg for
3 weeks and/or a combination of pyrimethamine
2 25 mg 4–8 weeks with sulfadiazine 50–75 mg/kg and
folic acid (leucovorin) 5 mg/day.
Best-corrected VA (BCVA) was the main parameter
of the visual function. At admission, BCVA40.3 was
observed in 35 patients (Table 2) and r0.3 (moderate and
severe visual impairment) in 24 patients, of which BCVA
was r0.1 (0.04±0.03) in as many as 21. At the end of
treatment, BCVA was improved in all; in those with
initial BCVA40.3, vision improved to almost normal
Table 1 Clinical and demographical characteristics in a series
of 59 patients with OT


















Type of lesion at 1st exam
Primary active lesion 21 35.6









Anterior uveitis 11 18.6
Retinal vasculitis 6 10.2
Complications of OT
CNV 2 3.4
Retinal detachmentþ cataract 1 1.7




At admission 0.69±0.40 0.02–1.0 P¼ 0.009
At the end 0.75±0.35 0.02–1.0
Left eye
At admission 0.68±0.37 0.0–1.0 P¼ 0.005
At the end 0.77±0.36 0.0–1.0
Days of stay in hospital
(mean±SE)
12.9±0.6 6–17







Time lapse from first to last admission (years)
4.1±0.9 1–9
aVisual acuity measured by Snellen chart at 6 m and converted to decimal
notation.
Table 2 Clinical characteristics and outcome of patients with








No. of patients 24 35






Vitritis 14 12 0.068
Anterior uveitis 5 6 0.721
Retinal vasculitis 2 4 0.699
Complications of OT
CNV 2 0 NA













Abbreviation: NA, not applicable because of low numbers.
aBetween all patients with central and peripheral lesions taken together.
bLocalized inside the vascular arcades (central and/or paracentral±
interpapillo-macular).
cLocalized out of the vascular arcades (juxtapapillar and/or peripheral).
dVisual acuity measured by Snellen chart at 6 m and converted to decimal
notation.
eBetween admission and end of treatment in groups of BCVAr and
40.3.
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levels and was obviously significantly (Po0.0001) better
than in those with initial BCVAr0.3. However, the
improvement in these latter (P¼ 0.006), as well as in
those with initial BCVAr0.1 (0.24±0.32; P¼ 0.01), was
clinically meaningful in only 10 patients, whereas 14
(24%) remained legally blind in the affected eye (Table 3).
Of these, there were 2 (3%) cases of bilateral blindness
(defined as BCVA of the better eye r0.1), whereas
unilateral legal blindness (BCVA of the affected eye
r0.1.) was observed in 12 (20%) patients. Patients who
ended up with unilateral or bilateral blindness had
extremely poor BCVA (0.047±0.055) at admission, which
did not improve with treatment (P¼ 0.808). Both
moderate and severe visual impairment at admission
and poor treatment outcome depended on the lesion
localization (Po0.0001 and P¼ 0.006, respectively),
occurring only in case of lesions within the vascular
arcades, whereas other ocular inflammation manifesta-
tions had no effect.
Discussion
Globally, there are wide variations in the distribution of
OT among all uveitis cases, with the smallest percentage
of OT observed in Japan (0.7%)14 and the highest in South
America (39.8%).15 Europe, North Africa, and USA range
between these two extremes (2.9–14%).16–21 Thus, the
data presented here from a Serbian referral centre
showing OT in 12.9% of all patients admitted for uveitis,
and in 24.3% of those with posterior uveitis, fit within
those for Europe.
In our series, primary OT was observed in one-third
and recurrent disease in two-thirds of all patients.
Primary OT at first presentation has been reported at
rates of 28–42.5%.5,6,22,23 The greater frequency of
recurrent disease may be accounted for by old peripheral
lesions that go unnoticed by the patient; this is also
supported by our clinical findings of a combination of
active lesions and old retinochoroidal scars at a greater
frequency than the patients were aware of.
Patient age is one of the several host factors that are
believed to influence the severity of OT, and OT tends to
be more severe at the extremes of age.24 Patients with OT
are generally young adults, and in our study group, 76%
of the patients were younger than 45 years. Similar
results were found in other studies,5,18,22,23,25 for instance,
Bosch-Driessen et al5 showed that the mean age at first
presentation of OT was 29.5 years and that patients with
primary ocular lesions were significantly older than
those with combinations of active lesions and old scars.
Also, Garweg et al25 reported that the mean age at the
first occurrence of OT was 23.9 years and patients with
only one episode were older at first manifestation than
those with two episodes (29.6 and 17.9 years,
respectively). However, in our series, although patients
with active primary OT were older than patients
with recurrent OT, the difference was not significant.
Even greater age differences have been reported
according to the origin of OT; that is, in the study of
Delair et al,6 patients with OT of congenital origin were
only 9.1 (±8.8) and those with acquired origin 21.7
(±12.6) years old. We were not able to distinguish
between congenital and acquired origin of OT, but
detection of Toxoplasma-specific IgM antibodies in a
single patient would indicate ophthalmic manifestations
coinciding with acute infection in 5% among patients
with primary OT. The proportion of OT concomitant with
acute toxoplasmosis based on the detection of serological
markers of acute infection (specific IgM/IgA antibodies)
has varied in different reports from 0% in a series in
Turkey26 to 11% in the Netherlands.5
At a rate of 73%, monocular presentation was clearly
predominant and was within the range (64.3–86.4%)
reported in other studies.18,22,23
Table 3 Clinical characteristics of OT patients with unilateral




No. of patients 14 (of which 2
bilateral)
45






Vitritis 8 18 0.259
Anterior uveitis 3 8 0.759
Retinal vasculitis 1 5 0.668
Complications of OT
CNV 1 1 NA
Retinal detachment 1 0
Secondary glaucoma 0 1
CMO 0 1
BCVAd at the admission
(mean±SD)
0.047±0.055 0.60±0.34o0.0001




Abbreviation: NA, not applicable due to very small numbers.
aBetween groups of patients with central and peripheral lesions taken
together.
bLocalized in the posterior pole (interpapillo-macular).
cLocalized out of the vascular arcades (juxtapapillar and/or peripheral).
dVisual acuity measured by Snellen chart at 6 m and converted to decimal
notation.
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Localization of retinal lesions was predominantly
within the vascular arcades, whereas peripheral lesions
and those multifocal outside the vascular arcades were
less common. This resulted in an end-of-treatment
unilateral legal blindness in 24% patients, all of which
had central lesions. Predominance of OT lesions
within the vascular arcades has been commonly
observed,5,18,22,23 for instance, of up to 84.2% of unilateral
and 75% of bilateral cases in Italy,18 in a tertiary setting
like ours where patients without visual impairment are
infrequent, and of 73% in a Colombian cohort study.22
In contrast, in a population-based study in Brazil,
peripheral lesions predominated (58.5%).27 However,
with regard to visual outcome, unilateral legal blindness
occurred in as many as 37.8% patients in the Colombian
study.22 This is substantially higher than the results
reported in Europe; the rate of 24% that we found was
virtually the same as the one reported by Bosch-Driessen
et al,5 whereas Scherrer et al28 found moderate to severe
impairment (VA o0.3 or 0.05, respectively) in 27.5% of
cases, which correlated with the central localization of
lesions. These opposing results obviously reflect the
general differences in the clinical evolution and severity
of Toxoplasma infection in South America vs Europe and
USA due to the above-mentioned differences in the
respective parasite genotypes.
Ocular symptoms of inflammation did not differ, in
type or in rate, from previous reports.22,26 However, the
rate of vitritis was lower than generally reported,22,26,29,30
which may suggest that the level of vitreous haze was
not always reliably recorded, particularly if low.
Complications of OT were not very marked. The 1.7% of
cataract was similar to the findings of Balasundaram et al30
and Tugal-Tutkun et al,26 but considerably lower than the
13% reported by Bosch-Driessen et al;5 the comparatively
high rate of complications in the latter series is presumably
due to the longer follow-up. Interestingly, although raised
IOP is often associated with an OT episode23,29,30 glaucoma
as a complication is rare; that is, in the study of Tugal-
Tutkun et al., although an IOP rise was seen in 8% patients
during active OT, there was no case of glaucoma as a
complication,26 nor was it seen in the series of
Balasundaram et al.30 In our series, one case was
complicated by glaucoma secondary to OT.
In conclusion, OT was found to be a common cause of
posterior uveitis in patients in Serbia. Given its vision-
threatening potential, patients with OT should be aware of
the recurring nature of their disease and react immediately
in case of visual symptoms. In addition, because of the
recently recognized significance of acquired toxoplasmosis
in the origin of OT, public health campaigns to increase
general public awareness of this infection are needed.
Further research should focus on distinguishing between
congenital and acquired infections in the origin of OT.
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